showed that gastric cancer cells can deliver PKM2 packed into EVs to macrophages, leading to the differentiation of macrophages into the pro-inflammatory M2 subtype, consequently promoting the progression of gastric cancer. This evidence concerns the gene PKM and gastric cancer.